The Binding Mode of the Sonic Hedgehog Inhibitor Robotnikinin, a Combined Docking and QM/MM MD Study

Manuel Hitzenberger1,2, Daniela Schuster3, Thomas S Hofer1

  • 1Theoretical Chemistry Division, Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.

Frontiers in Chemistry
|November 8, 2017
PubMed

Insights

This study reveals how robotnikinin binds to Sonic Hedgehog, a key protein in cancer development. Understanding these interactions aids in designing new drugs to inhibit the Hedgehog pathway and fight cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Aberrant Hedgehog pathway activation is implicated in numerous cancers.
  • Inhibiting the Sonic Hedgehog (SHH)-Patched 1 (PTCH1) interaction is a therapeutic target.
  • Robotnikinin is a known inhibitor of Sonic Hedgehog, but its binding mode is uncharacterized.

Purpose of the Study:

  • To elucidate the binding mode of robotnikinin to Sonic Hedgehog.
  • To identify key interactions stabilizing the Sonic Hedgehog-robotnikinin complex.
  • To provide a structural basis for developing novel Sonic Hedgehog inhibitors.

Main Methods:

  • Extensive molecular docking studies.
  • Molecular dynamics (MD) simulations.
  • Quantum mechanics/molecular mechanics (QM/MM) simulations.

Main Results:

  • Detailed characterization of the Sonic Hedgehog-robotnikinin binding mode.
  • Identification of critical protein-ligand interactions.
  • Stabilizing contributions to ligand binding elucidated.

Conclusions:

  • The study provides a structural understanding of robotnikinin's inhibition of Sonic Hedgehog.
  • The findings facilitate the design of new therapeutic agents targeting the Hedgehog pathway.
  • A PDB file of the complex is available for further research.